MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Functional stiff person like disorders: clinical features and red flags

B. Balint, A. Jha, M. Edwards, HM. Meinck, K. Bhatia (London, United Kingdom)

Meeting: 2019 International Congress

Abstract Number: 387

Keywords: Psychogenic movement disorders(PMD): Clinical features, Stiff-person syndrome

Session Information

Date: Monday, September 23, 2019

Session Title: Functional (Psychogenic) Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To delineate the characteristics and distinguishing features of functional stiff person-like disorders (fSPLD).

Background: Stiff person spectrum disorders (SPSD) are a group of rare autoimmune disorders, characterised by fluctuating stiffness, spasms, and hyperekplexia. The presentation of SPSD – the wooden, stiff-legged gait, the fear of walking unaided, the fluctuating nature of stiffness, and often the lack of other, “objective neurological signs” – can appear “bizarre” and leads frequently to an erroneous diagnosis of a functional neurological disorder. Conversely, we have seen several patients with functional “stiff-person-like” phenotypes, which were erroneously diagnosed and treated as organic SPSD.

Method: Retrospective dual-site case-control notes review of fSPLD with matched SPSD patients as controls. Participants were recruited from 2 centres (London and Heidelberg).  fSPLD patients have been referred with a suspected diagnosis of SPSD. fSPLD was defined by the diagnostic criteria for a clinically definite functional movement disorder.

Results: From 2014-2018, we (BB, KB) have seen 13 patients with a suspected diagnosis of SPSD. Four patients had in fact fSPLD, thus accounting for one third of referrals in one tertiary referral centre. Similar to organic SPSD where there are forms with dominant stiffness and predominantly myoclonic forms (“jerking stiff man”), we saw two main and equally frequent phenotypes in fSPLD: half of the patients had stiffness and spasms as main presentation; in the other half, stimulus-sensitive jerks and exaggerated startle were the dominating features. Some of the stiff-person core symptoms reported or exhibited by fSPLD patients resembled those seen in organic SPSD, such as a stiff legged-gait, trunk extension or opisthotonus during attacks, and painful spasms. Clinical characteristics particular to fSPLD included a “flexion pattern” of stiffness, functional jerks, or a co-contracting tremor. Additional functional symptoms (i.e., a functional gait disorder or speech disorder, dissociative disorder) were present in two thirds of the patients.

Conclusion: fSPLD represent a relevant differential diagnosis. Knowledge of the clinically distinguishing features and the role of ancillary testing is key for distinguishing fSPLD from SPSD, and initiating the appropriate treatment.

To cite this abstract in AMA style:

B. Balint, A. Jha, M. Edwards, HM. Meinck, K. Bhatia. Functional stiff person like disorders: clinical features and red flags [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/functional-stiff-person-like-disorders-clinical-features-and-red-flags/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/functional-stiff-person-like-disorders-clinical-features-and-red-flags/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley